Ebola infections in the Democratic Republic of the Congo have surpassed 11,300 reported cases alongside 5,500 deaths, according to figures released on Tuesday during a press briefing by the Director-General of the World Health Organization (WHO), as reported by Libnanews, Le Média Citoyen du Liban.
This latest update follows a prior count of 11,042 confirmed cases and 5,387 deaths recorded through November 9, 2026. Health authorities note that roughly half of all infected individuals do not survive.
Children face severe vulnerability in the ongoing health crisis, accounting for over a quarter of all cases and a third of all fatalities.
“C’est un public vulnérable, les enfants de moins de cinq ans sont très fortement touchés,” said Jérôme Kouachi, emergency programs manager for Unicef in the DRC, speaking on franceinfo. Kouachi added that response teams are prioritizing early detection to lower mortality rates and improve pediatric care within affected communities.
Financement de la riposte contre Ebola en RDC: les États-Unis transmettent au gouvernement la liste des agences bénéficiaires de leurs contributions estimées à plus de 400 millions USD https://t.co/L3v5pGkbLY
The current outbreak involves the Bundibugyo strain of the virus, for which no approved vaccine or treatment currently exists. In the Ituri territory, civil society reports indicate that logistical failures and resistance in villages like Lwemba and Malutu continue to disrupt safe burials and patient transfers, according to MediaCongo.
Vaccine Trials Scheduled
Two experimental vaccines specifically designed to target the Bundibugyo strain are scheduled to enter Phase 2 clinical trials in Bunia on November 26 or November 27, 2026, according to announcements by the Anadolu Ajansı. Dr. Meg Doherty of the WHO said that these candidate vaccines, developed respectively by the University of Oxford alongside the Serum Institute of India and by the American laboratory Moderna, received authorization to advance following initial evaluations.
#Ebola en #RDC : six mois après, plus de 11 000 cas et 5 400 décès selon l'OMS Six mois après le début de l'épidémie d'Ebola Bundibugyo en RDC, l'OMS fait état de plus de 11 000 cas et 5 400 décès. L'épidémie s'étend désormais à 67 zones de santé dans huit provinces, avec 400 à…
The trials operate under the Tumani study framework launched in late October, which has already enrolled more than 140 participants. Researchers intend to expand testing to additional sites utilizing mobile teams to assess both vaccine safety and immunogenicity.
Meanwhile, Médecins Sans Frontières has urged broader compassionate access to the existing Ervebo vaccine to protect frontline workers and high-risk contacts while specific new formulas remain under evaluation, as noted by Médecins Sans Frontières (MSF).
Security Crisis Hinders Medical Access
Persistent armed conflict across eastern provinces continues to severely hamper epidemiological tracking and medical interventions. United Nations officials note that attacks by the Allied Democratic Forces have claimed more civilian lives in certain areas than the virus itself, with over 80 documented assaults on healthcare structures and personnel, according to UN News.
An attack in Cantine-Aloya resulted in the deaths of 66 civilians, including three healthcare workers, and disrupted the monitoring of more than 1,000 active infection contacts.

The WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, emphasized that community mistrust and ongoing violence drive many patients to seek care too late, with two-thirds of confirmed deaths occurring outside designated treatment centers.
“Elle se gagne par l’écoute, le respect et une prise en charge empreinte de compassion, afin que les personnes se fassent soigner dès les premiers symptômes, au moment où il est encore possible de sauver des vies,” Tedros said on the social media platform X.
Frequently Asked Questions About the Outbreak
Which virus strain is causing the current outbreak in the Democratic Republic of the Congo?
The outbreak is driven by the Bundibugyo strain of the Ebola virus, which differs from the Zaire strain encountered during previous major epidemics in West Africa and earlier Congolese outbreaks, according to Libnanews, Le Média Citoyen du Liban.
Six months ago, I declared the Bundibugyo virus #Ebola outbreak in the #DRC a Public Health Emergency of International Concern. Since then, over 11,000 cases and 5400 deaths have been recorded across eight provinces, making this the largest and deadliest Ebola outbreak in the… pic.twitter.com/v1TncZkxJs
When are the Phase 2 clinical trials for the new candidate vaccines expected to begin?
Clinical trials for the two new candidate vaccines developed against the Bundibugyo strain are set to begin on November 26 or November 27, 2026, in Bunia, according to the Anadolu Ajansı.
How many healthcare attacks have been recorded during this health emergency?
United Nations reporting documents more than 80 security attacks directed against health structures and medical personnel since the epidemic was officially declared, as detailed by UN News.
Earlier coverage: DRC Ebola Death Toll Passes 5,500 as Violence Hampers Response
Keep reading